The potential impact of COVID-19 in refugee camps in Bangladesh and beyond:  A modeling study

Autoři: Shaun Truelove aff001;  Orit Abrahim aff001;  Chiara Altare aff001;  Stephen A. Lauer aff001;  Krya H. Grantz aff001;  Andrew S. Azman aff001;  Paul Spiegel aff001
Působiště autorů: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America aff001;  Infectious Disease Dynamics Group, Baltimore, Maryland, United States of America aff002;  Center for Humanitarian Health, Baltimore, Maryland, United States of America aff003;  International Vaccine Access Center, Baltimore, Maryland, United States of America aff004
Vyšlo v časopise: The potential impact of COVID-19 in refugee camps in Bangladesh and beyond:  A modeling study. PLoS Med 17(6): e32767. doi:10.1371/journal.pmed.1003144
Kategorie: Research Article
doi: 10.1371/journal.pmed.1003144



COVID-19 could have even more dire consequences in refugees camps than in general populations. Bangladesh has confirmed COVID-19 cases and hosts almost 1 million Rohingya refugees from Myanmar, with 600,000 concentrated in the Kutupalong-Balukhali Expansion Site (mean age, 21 years; standard deviation [SD], 18 years; 52% female). Projections of the potential COVID-19 burden, epidemic speed, and healthcare needs in such settings are critical for preparedness planning.

Methods and findings

To explore the potential impact of the introduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Kutupalong-Balukhali Expansion Site, we used a stochastic Susceptible Exposed Infectious Recovered (SEIR) transmission model with parameters derived from emerging literature and age as the primary determinant of infection severity. We considered three scenarios with different assumptions about the transmission potential of SARS-CoV-2. From the simulated infections, we estimated hospitalizations, deaths, and healthcare needs expected, age-adjusted for the Kutupalong-Balukhali Expansion Site age distribution. Our findings suggest that a large-scale outbreak is likely after a single introduction of the virus into the camp, with 61%–92% of simulations leading to at least 1,000 people infected across scenarios. On average, in the first 30 days of the outbreak, we expect 18 (95% prediction interval [PI], 2–65), 54 (95% PI, 3–223), and 370 (95% PI, 4–1,850) people infected in the low, moderate, and high transmission scenarios, respectively. These reach 421,500 (95% PI, 376,300–463,500), 546,800 (95% PI, 499,300–567,000), and 589,800 (95% PI, 578,800–595,600) people infected in 12 months, respectively. Hospitalization needs exceeded the existing hospitalization capacity of 340 beds after 55–136 days, between the low and high transmission scenarios. We estimate 2,040 (95% PI, 1,660–2,500), 2,650 (95% PI, 2,030–3,380), and 2,880 (95% PI, 2,090–3,830) deaths in the low, moderate, and high transmission scenarios, respectively. Due to limited data at the time of analyses, we assumed that age was the primary determinant of infection severity and hospitalization. We expect that comorbidities, limited hospitalization, and intensive care capacity may increase this risk; thus, we may be underestimating the potential burden.


Our findings suggest that a COVID-19 epidemic in a refugee settlement may have profound consequences, requiring large increases in healthcare capacity and infrastructure that may exceed what is currently feasible in these settings. Detailed and realistic planning for the worst case in Kutupalong-Balukhali and all refugee camps worldwide must begin now. Plans should consider novel and radical strategies to reduce infectious contacts and fill health worker gaps while recognizing that refugees may not have access to national health systems.

Klíčová slova:

Bangladesh – Death rates – Epidemiology – Health systems strengthening – Hospitalizations – Intensive care units – Respiratory infections – SARS


1. United Nations High Commissioner for Refugees. Bangladesh: Operational Update. 2019.

2. United Nations High Commissioner for Refugees. Country Profile: Rohingya Refugee Response Bangladesh. 2019.

3. UNHCR Mapping Unit. Rohingya Refugee Emergency at a Glance 2018 [March 9, 2020]. Available from:

4. ACAPS. COVID-19: Impact on the Rohingya Response. 2020.

5. Strategic Executive Group. 2020 Joint Response Plan Rohingya Humanitarian Crisis. 2020.

6. Emergency nutrition and health assessment, round 4, Cox’s Bazar, Bangladesh, September–October 2019, preliminary results.

7. United Nations High Commissioner for Refugees. Dashboard—Public Health. 2019.

8. MSF. Bangladesh Emergency Response Crises Info #9 –September 2018. 2018.

9. World Health Organization. Rohingya Crisis in Cox’s Bazar, Bangladesh: Health Sector Bulletin. Bulletin. 2018;(05).

10. World Health Organization, United Nations High Commissioner for Refugees, International Organization for Migration, Swiss Agency for Development and Cooperation, United Nations Population Fund. Available Services in Sadar Hospital, Ukhia and Teknaf Health Complexes. 2017.

11. MSF. International Activity Report 2018 Bangladesh 2018 [March 9, 2020]. Available from:

12. Government of People's Republic of Bangladesh Ministry of Health and Family Welfare. Facility Registry: Cox's Bazar 250 Bed District Sadar Hospital 2020 [March 9, 2020]. Available from:

13. Global Health Workforce Alliance. Bangladesh: World Health Organization; 2011 [March 9, 2020]. Available from:

14. World Health Organization. Health workforce requirements for universal health coverage and the Sustainable Development Goals.(Human Resources for Health Observer, 17). 2016.

15. Bjørnstad O. SEIR model. McMaster University 2005. p. 1–8.

16. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner NW, Ke R. The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated. arXiv preprint arXiv:200203268. 2020.

17. White LF, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza and Other Respiratory Viruses. 2009;3(6):267–76. doi: 10.1111/j.1750-2659.2009.00106.x 19903209

18. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. medRxiv [preprint]. 2020.

19. Truelove SA, Keegan LT, Moss WJ, Chaisson LH, Macher E, Azman AS, et al. Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis. Clinical Infectious Diseases. 2019. doi: 10.1093/cid/ciz808 31425581

20. COVID-19 Parameter Estimates: Github; 2020 [March 9, 2020]. Available from:

21. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv [preprint] 2020.

22. United Nations Population Division. World Population Prospects: 2019 Revision. United Nations New York, NY; 2019.

23. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine. 2020.

24. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.

25. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. medRxiv [preprint]. 2020:2020.03.02.20030452. doi: 10.1101/2020.03.02.20030452

26. Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 2020.

27. Russell TW, Hellewell J, Jarvis CI, Van-Zandvoort K, Abbott S, Ratnayake R, et al. Estimating the infection and case fatality ratio for COVID-19 using age-adjusted data from the outbreak on the Diamond Princess cruise ship. medRxiv [preprint]. 2020.

28. COVID CDC Reponse Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–6. doi: 10.15585/mmwr.mm6912e2 32214079

29. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020:e20200702. doi: 10.1542/peds.2020-0702 32179660

30. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020.

31. Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. British Medical Journal Publishing Group; 2020.

32. Tay A, Riley A, Islam R, Welton-Mitchell C, Duchesne B, Waters V, et al. The culture, mental health and psychosocial wellbeing of Rohingya refugees: a systematic review. Epidemiology and psychiatric sciences. 2019;28(5):489–94. doi: 10.1017/S2045796019000192 31006421

33. Dahab M, Zandvoort Kv, Flasche S, Warsame A, Spiegel PB, Waldman RJ, et al. COVID-19 control in low-income settings and displaced populations: what can realistically be done?2020 March 21, 2020. Available from:

34. Bond N, Sesay S, Kamara A, Bates J, Teigen J, Stowlow J, et al. Ebola Survivor Corps: employing Ebola survivors as health educators and advocates in communities affected by Ebola in northern Sierra Leone. The Lancet Global Health. 2019;7:S48. doi: 10.1016/S2214-109X(19)30133-0

35. Parmar PK, Jin RO, Walsh M, Scott J. Mortality in Rohingya refugee camps in Bangladesh: historical, social, and political context. Sexual and Reproductive Health Matters. 2019;27(2):39–49. doi: 10.1080/26410397.2019.1610275 31533592

36. Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Effects of response to 2014–2015 ebola outbreak on deaths from malaria, HIV/AIDS, and tuberculosis, West Africa. Emerging Infectious Diseases. 2016;22(3):433–41. doi: 10.3201/eid2203.150977 26886846

37. Mahase E. Measles: Democratic Republic of the Congo recorded over 6000 deaths last year. British Medical Journal Publishing Group; 2020.

38. Inter-Agency Standing Committee. Scaling-up COVID-19 Outbreak Readiness and Response Operations in Humanitarian Situations Including Camps and Camp-Like Settings. 2020.

39. World Health Organization. 2019 Novel Coronavirus (2019‐nCoV): Strategic Preparedness and Response Plan. 2020.

40. UN Refugee Agency. Global Trends: Forced Displacement in 2018. 2019.

41. Joint Statement on US-Mexico Joint Initiative to Combat the COVID-19 Pandemic [Internet]. 2020. Available from:

Interní lékařství

Článek vyšel v časopise

PLOS Medicine

2020 Číslo 6

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…

Kurzy Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se

VIRTUÁLNÍ ČEKÁRNA ČR Jste praktický lékař nebo pediatr? Zapojte se! Jste praktik nebo pediatr? Zapojte se!